TREATMENT OF MIGRAINE & CLUSTER HEADACHE
|
|
- Marcus Daniel
- 7 years ago
- Views:
Transcription
1
2 TREATMENT OF MIGRAINE & CLUSTER HEADACHE
3 Management of Migraine Principles Adequate relief of pain during the acute attack Measures to prevent recurrence of attacks Identification and management of triggers General measures There is no cure
4 Management of migraine General measures Rest in a dark, quiet room Adequate rehydration May need antiemetic
5 Management of Migraines Pharmacological A. Treatment of the acute attack B. Prophylactic therapy Non-Pharmacological Trigger management, Stress Management, Lifestyle modifications, Exercises, Relaxation methods, etc
6 Drug groups: Migraines-management Acute attack A. Analgesics: NSAIDs & Opoids,etc. B. Anti emetics: Metoclopramide (Maxolon), Dromperidone (motilium), Stemetil, etc. C. Ergot Alkaloids: Ergotamine tartarate, etc. D. Triptans: Zolmatriptan(Zomig), Sumatriptan, etc E. Miscellaneous Diazepam, steroids, etc.
7 Migraines-management -Acute attack Analgesics and anti-emetics Both NSAIDS and opoid group of analgesics are useful in the treatment of pain in the acute migraine attack. IV/IM preparations in moderate to severe attacks Use along with anti-emetics improves absorption, reduces nausea, and potentiates headache relief.
8 Migraines-management -Acute attack Analgesics NSAIDS: ibuprofen mg. daily naproxen diclofenac mg. daily mg. daily -IM 75 mg. Opoids: dextropropoxyphene, pentazocine mg. PO/IV petihdine/morphine Others: paracetamol, mefanemic acid, acetaminophen, etc.
9 Migraines-management -Acute attack The ergot alkaloids. non-selective 5HT1 agonists very useful in the management of acute migraine attacks use restricted at times by acute and chronic side effects (vomitting and ergotism) best when used early in the attack much better effects, when administered IV, PR (only oral form available in Pakistan)
10 Migraines-management -Acute attack The ergot alkaloids. Preparations: Ergotamine tartarate: Dihydroergotamine: Caffergot, Migril, etc. Dose 1-2 mg, max 6 mg/day DHE,-IV and nasal spray dose-1mg, max 3-4 mg. more effective, useful in any stage of the attack Ergots are preferably used with antiemetics
11 Migraines-management -Acute attack The Triptans The triptans are specific and selective medications used in the treatment of acute attacks of migraines These have affinity only to 5HT1B/1D receptors. They are therefore cleaner drugs with a more specifically directed effect, and lesser side effects
12 Migraines-management -Acute attack The Triptans Preparations: (1) Sumatriptan tabs -50 mg. (Imigran) sc -6 mg. nasal spray (2) Zolmatriptan tabs -2.5/5mg. (Zomig) nasal spray - 20 mg. (3) Others Naratriptan, Rizatriptan Eletriptan, etc
13 Optimization of pain relief Administration of a Triptan along with an NSAID (naproxen) gives much better relief from acute migraines than triptan or NSAID alone (Brandes JL et al, JAMA 2007) For best relief, treatment for the acute attack should be started as soon as possible after the onset of the headache phase within half hour. Not to start treatment during aura or anytime before the onset of actual headaches
14 Contraindications of triptans Untreated arterial hypertension, Coronary heart disease Raynaud s disease History of ischaemic stroke Pregnancy Lactation Severe liver or renal failure.
15 Migraines-management -Acute attack: Clinical approach Clinical practices vary. Broad principles can be stratified according to the severity of the acute attack. mild attack moderate attack severe attack very severe attack, including status migrainosus
16 Migraines-management -Acute attack: Clinical approach Mild attack Moderate attack Severe attack Very severe attacks simple analgesics, NSAIDS, NSAIDS, oral ergots, oral triptans, antiemetics ergots IV/IM/sc, nasal, PR triptans oral/sc, antiemetics IV NSAIDS, IV DHE, steroids, IV opiods, IV antiemetics, dopamine antagonists (bromocriptine)
17 Triptans available in Pakistan: Sumatriptan 50mg oral Zolmitriptan 2.5-5mg oral
18 Treatment of Migraines - Prophylaxis
19 Indications for prophylaxis More than 4 headaches/month headaches lasting > 12 hours If the headaches are frequent, long lasting and amount to a significant amount of total disability Uptodate Nov 2012
20 Indications for prophylaxis To prevent neurologic damage in the presence of uncommon migraine conditions including Hemiplegic migraine Basilar type migraine Migraine with prolonged aura Migrainous infarction Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754.
21 Migraine prophylaxis Avoidance of trigger factors Lifestyle modification Prophylactic medications
22 Goals of prophylaxis Reduce the attack frequency, severity, and disability. Avoid acute medication overuse that may lead to medication overuse headache Improve the quality of life. Reduce headache-related distress and psychological symptoms.
23 Duration of Prophylaxis Preemptive: pre-treat before a known trigger e.g high altitude, exercise Short term e.g menstrual migraine Long term when migraine interferes with ADL
24 Lifestyle modifications maintain a regular lifestyle, adequate sleep, timely meals, regular exercise manage stress Identify triggers and avoid them. adequately control their migraine attacks.
25 Principles of Prophylaxis Initiate medications with the best evidence-based efficacy the lowest effective dose of the drug titrate dose slowly until clinical benefits are achieved without any adverse events give adequate trial of 2-3 m to each drug Avoid multiple prophylactic agents long-acting formulations may improve compliance
26 Prophylactic agents for migraine Beta-blockers Propranolol Atenolol Metoprolol Antiserotonin Pizotifen Calcium-channel blockers Verapamil Flunarizine (Sibelium) Antidepressants Tricyclics SSRI Anticonvulsants Valproate Topiramate (Topamax)
27 Peer C. Tfelt-Hansen & Anders Hougaard. Migraine:New US guidelines for preventive treatment of migraine. Nature Reviews Neurology 8, (August 2012)
28 Migraine prophylaxis suggested dosages of common drugs Propranolol 30 to 240 mg/day in divided doses Topiramate 50 to 100 mg/day in divided doses Amitryptiline 25 to 75 mg/day single dose at night Valproate 500 to 1000mg/day in 2 divided doses
29 Migraine prophylaxis suggested dosages of common drugs Flunarizine 5 to 10 mg/day single night time dose Pizotifen 1 to 3 mg/day single night time dose Gabapentin 900 to 1800 mg/day in 3 divided doses
30 Choosing the right prophylactic agent Co-morbid condition Cost Compliance Family history
31 Drugs of choice for co-morbid conditions Co-morbid condition Depression Insomnia Bipolar mood disorder Neuralgic pain HTN Hypotension Asthma Obesity Anorexia Drug suggested Amitryptaline, SSRI s, avoid beta blockers Amitryptaline Divalpr Na, Topiramate Amitryptaline Beta blockers Divalpr Na, Topiramate. Avoid Amytryptaline Beta blockers contra indicated Topiramate Amitryptalne, Flunarizine, Pizotifen Shukla R, Sinha M. Migraine :Prophylactic Treatment SUPPLEMENT OF JAPI april 2010 VOL. 58
32 Migraines-prophylaxis General principles of management Start small, go slow. Adequate trial of one drug in an optimum dose for at least 3 months, before pronouncing it as ineffective. Withdraw medication gradually Response varies from individual to individual At times combination therapy is helpful
33 Duration of migraine prophylaxis Variable Don t rush in discontinuing therapy Counsel about need of long term treatment at the beginning? 3 months to 2 years
34 Take home message Migraine prophylaxis is effective but underused Prophylaxis may be pre-emptive, short-term mini-prophylaxis or long term Choose the agent according to established guidelines as far as possible Tailor the therapy according to your patient s need and co-morbid condition Counsel your patient when you start therapy
35 Cluster headaches Acute Treatment
36 Cluster headaches - Prophylaxis
37 Trigeminal Neuralgia - Medical Treatment Carbamezapine to 1200 mg daily Oxcarbazepine (better tolerated, less well studied) 600 to 2400 mg daily Gabapentin to 2400 mg daily Lioresal (Baclofen) - 10 mg to 60 mg daily Phenytoin 200 to 600 mg. daily as tolerated Others Lamotrigine, Pregabalin, Botulinum toxin, etc
38 Trigeminal Neuralgia Surgical Treatment Microvascular decompression (Jannetta s Procedure) Decompression of the trigeminal nerve from the compression / pulsating artery in the brainstem 75% pain relief at 5 years Percutaneous procedures (not available in Pakistan) 1. PC retrogasserian glycerol rhizotomy 2. PC balloon microcompression Gamma Knife Surgery (available in Karachi) minimally invasive, high rate of pain relief
39 THANK YOU Become a member of Pakistan Headache Society(PHS) by downloading form from
40
41
42
43 Outline Clinical Scenario Goals Duration Principles Indications Comparison of American & European guidelines Take home Message
44 Clinical Scenario 47 year old male. Hx of migraine headaches since 24 years age. Maternal aunt, and brother suffer from similar headaches. Severe, L>R, throbbing, nausea, photo and phonophobia. Rarely visual aura zig zag scintillations. Precipitated by sleep deprivation, hunger (first 1-2 days of Ramadan), Pizza, sweet melon Frequency 2-3/week
45 Epidemiology Approximately 38% of migraineurs need preventive therapy But only 3% 13% currently use it. Ref:Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF; The American Migraine Prevalence and Prevention Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68:
Headaches in Children How to Manage Difficult Headaches
Headaches in Children How to Manage Difficult Headaches Peter Procopis Childhood headaches Differential diagnosis Migraine Psychological Raised Pressure Childhood headaches Other causes: Constitutional
More informationHEADACHE. as. MUDr. Rudolf Černý, CSc. doc. MUDr. Petr Marusič, Ph.D.
HEADACHE as. MUDr. Rudolf Černý, CSc. doc. MUDr. Petr Marusič, Ph.D. Dpt. of Neurology Charles University in Prague, 2nd Faculty of Medicine Motol University Hospital History of headache 1200 years B.C.
More informationMigraine The Problem: Common Symptoms:
Migraine The Problem: A combination of genetic and environmental factors alter pain mechanisms in your brain Transient changes in brain chemicals such as serotonin and neuropeptides affect the membranes
More informationMIGRAINE. Denise Cambier M.D. Delaware Neurology, Ohio Health March 2013
MIGRAINE Denise Cambier M.D. Delaware Neurology, Ohio Health March 2013 HISTORY: Graham and Wolff 1938: decreased amplitude of arterial pulsations coincided with reduction of headache with IV ergotamine.
More informationEvaluation of Headache Syndromes and Migraine
Evaluation of Headache Syndromes and Migraine Sonja Potrebic MD PhD Department of Neurology Los Angeles Kaiser Objectives 1) Identify the diagnostic features of migraine Differentiate from sinusitis 2)
More informationSporadic attacks of severe tension-type headaches may respond to analgesics.
MEDICATIONS While we are big advocates of non-drug treatments, many people do require the use of medications to control headaches. Headache medications are divided into two categories. Abortive drugs are
More informationSIGN. Diagnosis and management of headache in adults. Quick Reference Guide. Scottish Intercollegiate Guidelines Network
SIGN Scottish Intercollegiate Guidelines Network 107 iagnosis and management of headache in adults Quick Reference Guide November 2008 opies of all SIGN guidelines are available online at www.sign.ac.uk
More informationEmergency and inpatient treatment of migraine: An American Headache Society
Emergency and inpatient treatment of migraine: An American Headache Society survey. The objective of this study was to determine the practice preferences of AHS members for acute migraine treatment in
More informationHEADACHES IN CHILDREN AND ADOLESCENTS. Brian D. Ryals, M.D.
HEADACHES IN CHILDREN AND ADOLESCENTS Brian D. Ryals, M.D. Frequency and Type of Headaches in Schoolchildren 8993 children age 7-15 in Sweden Migraine in 4% Frequent Nonmigrainous in 7% Infrequent Nonmigrainous
More informationMigraine Treatment - What You Should Know
What kind of headache do you have? Less than 2% of the population have never had a headache. Most of us get them from time to time and they are usually resolved with a couple of painkillers, a rest or
More information8/23/2015 A PRACTICAL OPTOMETRIC HEADACHE APPROACH A PRACTICAL OPTOMETRIC HEADACHE APPROACH A PRACTICAL OPTOMETRIC HEADACHE APPROACH
8/23/2015 A Practical Optometric Approach To Headaches Leonid Skorin, Jr., OD, DO, MS, FAAO, FAOCO Consultant, Department of Surgery Community Division of Ophthalmology Mayo Clinic Health System in Albert
More informationHeadaches in Children
Children s s Hospital Headaches in Children Manikum Moodley, MD, FRCP Section of Pediatric Neurology The Cleveland Clinic Foundation Introduction Headaches are common in children Most headaches are benign
More informationTension-type headache Non-pharmacological and pharmacological treatment
Danish Headache Center Tension-type headache Non-pharmacological and pharmacological treatment Lars Bendtsen Associate professor, MD, PhD, Dr Med Sci Danish Headache Center, Department of Neurology Glostrup
More informationWhat is chronic daily headache? Information for patients Neurology
What is chronic daily headache? Information for patients Neurology What is chronic daily headache (CDH)? Chronic daily headache (CDH) is the term used when a person has a headache on 15 days a month or
More informationEvidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management of Acute Attacks
Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management of Acute Attacks David B. Matchar, MD Professor of Medicine and Director, Center for Clinical Health
More informationNone related to the presentation Grants to conduct clinical trials from:
Chronic Daily Headache Bassel F. Shneker, MD, MBA Associate Professor Vice Chair, OSU Neurology The Ohio State University Wexner Medical Center Financial Disclosures None related to the presentation Grants
More informationLevels of evidence and grades of recommendation
MOH Clinical Practice Guidelines 5/2007 Levels of evidence and grades of recommendation Levels of evidence Level Type of Evidence 1 + + High quality meta-analyses, systematic reviews of randomised controlled
More informationAdult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention
Adult with headache Problem-specific video guides to diagnosing patients and helping them with management and prevention London Strategic Clinical Networks London Neuroscience Strategic Clinical Network
More informationTension-type headache Non-pharmacological and pharmacological treatment
Danish Headache Center Tension-type headache Non-pharmacological and pharmacological treatment Lars Bendtsen Associate professor, MD, PhD, Dr Med Sci Danish Headache Center, Department of Neurology Glostrup
More informationProper Diagnosis and Treatment for the Headache Patient Alexander Feoktistov MD, PhD
Proper Diagnosis and Treatment for the Headache Patient Alexander Feoktistov MD, PhD Director of Clinical Research Diamond Headache Clinic Chicago, IL 2014 Objectives Get familiar with primary headache
More informationWHAT IS MIGRAINE? Aura without Headache About 1% of migraineurs experience the aura symptoms of migraine without ever having a headache.
WHAT IS MIGRAINE? Migraine is the most common neurological condition in the world, affecting about 1 in 10 people. It is 3 times more common in women and is usually inherited. It is a very individual condition.
More informationHEADACHE: CLINICAL SYNDROMES, PATHOPHYSIOLOGY AND MANAGEMENT Joanna G Katzman, M.D., MSPH Assistant Professor UNM Pain Center and ECHO Pain
HEADACHE: CLINICAL SYNDROMES, PATHOPHYSIOLOGY AND MANAGEMENT Joanna G Katzman, M.D., MSPH Assistant Professor UNM Pain Center and ECHO Pain University of New Mexico Health Sciences Center 11/14/13 After
More information4.1 How can migraine treatments be assessed and rated? 86 STRATEGIES FOR USING MIGRAINE THERAPIES
Migraine treatments 4 4.1 How can migraine treatments be assessed and rated? 86 STRATEGIES FOR USING MIGRAINE THERAPIES 4.2 What are the strategies for treating migraine? 86 4.3 How should behavioural
More informationAdvances in Migraine Management: Implications for Managed Care Organizations
In response to the expense of new migraine therapies, treatment practices aimed at controlling direct costs are now the norm. Advances in Migraine Management: Implications for Managed Care Organizations
More informationTreatment Options for Acute Migraine
Treatment Options for Acute Migraine a report by Andrew J Dowson Director of the King s Headache Service, King s College Hospital DOI:10.17925/ENR.2006.00.02.28 Introduction Migraine Treatments Andrew
More informationViews and Perspectives
Headache 2010 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2010.01764.x Published by Wiley Periodicals, Inc. Views and Perspectives Defining the Pharmacologically Intractable Headache
More informationPost-Concussive Headaches and Dizziness Louise M. Klebanoff, MD
Post-Concussive Headaches and Dizziness Louise M. Klebanoff, MD Associate Professor and Vice Chairman for Operations Chief, General Neurology Department of Neurology Disclosures: None Introduction: Headaches
More informationContents Page. 1. What is IV DHE? 3. 2. Medication Licence 3. 3. How can a course of IV DHE help? 4. 4. What are the side effects of IV DHE?
If you would like this document in another language or format, or if you require the services of an interpreter, please contact us on extension 84299 or 83926. Switchboard: 0845 155 5000 020 3456 7890
More informationHeadache - What is Your Migraine Size?
Headache The Pharmacist s Role in Assessment & Peter Loewen, B.Sc.(Pharm), Pharm.D. Vancouver Hospital & Health Sciences Centre University of British Columbia ETC, Headache. Nan Quintin www.vhpharmsci.com
More informationJuly 2012 Target Population. Adult patients 18 years or older in primary care settings.
Guideline for Primary Care Management of Headache in Adults July 2012 Target Population Adult patients 18 years or older in primary care settings. Exclusions: This guideline does not provide recommendations
More informationHeadaches. This chapter will discuss:
C H A P T E R Headaches 1 1 Almost everyone gets an occasional headache at some time or another. Some people get frequent headaches. Most people do not worry about headaches and learn to live with them
More informationAcute and Preventive Treatment of Migraine Paul B. Rizzoli, MD, FAAN
Review Article Address correspondence to Dr Paul B. Rizzoli, BW/Faulkner Neurology, John R. Graham Headache Center, 1153 Centre St, Suite 4970, Jamaica Plain, MA 02130, prizzoli@partners.org. Relationship
More information11/18/2015. Neurology Update Migraine Headaches. Disclosure Statement. Objectives. Diagnosis of Migraine. Acute Migraine Treatment
Disclosure Statement Neurology Update Migraine Headaches Ralph T. Dunnigan, M.D. Mid Dakota Clinic Bismarck ND DISCLOSURE OF CONFLICT OF INTEREST A commercial interest is any entity producing, marketing,
More informationControversies in Migraine Management
Controversies in Migraine Management A Technology Assessment Final Report August 19, 2014 Completed by: Institute for Clinical and Economic Review Institute for Clinical and Economic Review, 2014 AUTHORS:
More informationAcute Migraine Treatment
Acute Migraine Treatment 1 ACUTE MIGRAINE TREATMENT Objectives Review the general principles and clinical evidence for acute treatment Present an approach for selecting and sequencing acute therapies Discuss
More informationHeadaches and Kids. Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital
Headaches and Kids Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital Overview Headache classifications and diagnosis Address common headache
More informationAcute Treatment of Migraine
Acute Treatment of Migraine Headache Cooperative of New England (HCNE) Topnotch at Stowe, VT March 6, 2009 ALAN M. RAPOPORT, M.D. Founder and Director-Emeritus The New England Center for Headache Stamford,
More informationCases in Neurology. Migraine is the most common cause of recurrent. What to do About the Child with Headaches. Case 1: Mary s pain
What to do About the Child with Headaches Sheikh Nigel Basheer, MB; and Kevin Farrell, MB Presented at UBC s 11th Annual Pediatric and Adolescent Refresher for General Practitioners, 2003 Migraine is the
More informationNew appendix criteria open for a broader concept of chronic migraine
Blackwell Publishing LtdOxford, UKCHACephalalgia0333-1024Blackwell Science, 20062006266742746Original ArticleA broader concept of chronic migrainej Olesen et al. BRIEF REPORT New appendix criteria open
More informationMigraine Agents Quantity Limit Program Summary
Migraine Agents Quantity Limit Program Summary Program applies to GenRx Open, GenRx Closed, Health Insurance Marketplace, FlexRx Open, FlexRx Closed and Medicaid. For the GenRx Closed Formulary, nonpreferred
More informationSumatriptan (Imitrex ) Utilization Management Criteria
Sumatriptan (Imitrex ) Utilization Management Criteria DRUG CLASS: BRAND (generic) NAME: 5HT1 agonists Imitrex (sumatriptan) Sumavel DosePro (sumatriptan) Injection kit or refill (GCN = 050741) Injection
More informationReview for NHS Surrey Prescribing Clinical Network. Treatment: Botox for chronic migraine. Prepared by: Victoria Overland
Review for NHS Surrey Prescribing Clinical Network Treatment: Botox for chronic migraine Prepared by: Victoria Overland Date: To be considered at September 2012 PCN meeting 1. Purpose of the Review NICE
More informationAmerican Headache Society Evidence Assessment
Headache 2015 American Headache Society ISSN 0017-8748 doi: 10.1111/head.12499 Published by Wiley Periodicals, Inc. American Headache Society Evidence Assessment The Acute Treatment of Migraine in Adults:
More informationAcute treatment of migraine headache
Techniques in Regional Anesthesia and Pain Management (2009) 13, 9-15 Acute treatment of migraine headache Marisa Chang, MD, a Alan M. Rapoport, MD a,b From the a Department of Neurology, The David Geffen
More informationDiagnosis and Management of Migraine Headaches
Diagnosis and Management of Migraine Headaches Elizabeth C. Lawrence, MD Abstract: Migraine headaches afflict approximately 6% of men and 18% of women in the United States, and cost billions of dollars
More informationHeadaches in Primary Care: An Approach to Management 2015 Update
Headaches in Primary Care: An Approach to Management 2015 Update Kathleen B. Digre MD Professor Neurology, Ophthalmology Adjunct Professor Anesthesia, Obstetrics and Gynecology UNIVERSITY OF UTAH Disclosures:
More informationUniversity of Arkansas Medical Sciences
TELE-REHABILITATION INTERVENTIONS GUIDELINE Management of Headaches in the Patient with Post Traumatic Brain Injury Drafted: 6-18-15 Peer Reviewed: Finalized:7-1-15 I. Definition, Assessment, Diagnosis
More informationGuidance for Industry Migraine: Developing Drugs for Acute Treatment
Guidance for Industry Migraine: Developing Drugs for Acute Treatment DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
More informationREVIEW PREVENTIVE THERAPY FOR MIGRAINE HEADACHE. Carla Rubingh, PharmD * ABSTRACT
PREVENTIVE THERAPY FOR MIGRAINE HEADACHE Carla Rubingh, PharmD ABSTRACT Headache is one of the most common medical complaints. It is estimated that the prevalence of migraine is approximately 13% (18%
More informationSUMATRIPTAN (IMITREX ) UTILIZATION MANAGEMENT CRITERIA
SUMATRIPTAN (IMITREX ) UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: 5HT1 agonists BRAND NAME: Imitrex 4 mg injection kit or refill (Generic) (sumatriptan) 6 mg injection kit or refill Injection vial (1
More informationWeb: www.migraine.org.uk. Medication overuse headache and undergoing a detox programme
Web: www.migraine.org.uk Medication overuse headache and undergoing a detox programme Web: www.migraine.org.uk/moh What is medication overuse headache? Medication taken to help relieve migraine attacks
More informationAppendix 1 (as supplied by the authors): Framework and content of the intervention of the LIMIT study
Appendix 1 (as supplied by the authors): Framework and content of the intervention of the LIMIT study Background The training was based on the learning cycle of Kolb 1. According to this cycle effective
More informationPatient Information ONZETRA TM (On ze' trah) Xsail TM (Eks'-seil) (sumatriptan nasal powder) 11 mg
Patient Information ONZETRA TM (On ze' trah) Xsail TM (Eks'-seil) (sumatriptan nasal powder) 11 mg Read this Patient Information before you start using ONZETRA Xsail and each time you get a refill. There
More informationPlease be sure to list all therapies that have been previously tried on the request form so that your request can be processed in a timely manner.
Drug Therapy Guidelines: Migraine Agents Axert (almotriptan), Relpax (eletriptan), Frova (frovatriptan), Amerge (naratriptan), Maxalt/MLT (rizatriptan), Imitrex (sumatriptan), Zomig/ZMT (zolmitriptan),
More informationAcute & Prophylactic Treatments for Migraine Headache
Acute & Prophylactic Treatments for Migraine Headache Release Date: 03/08/2012 Expiration Date: 03/08/2015 FACULTY: Lenore Howe, BS, MS FACULTY AND ACCREDITOR DISCLOSURE STATEMENTS: Ms. Howe has no actual
More informationMedical wisdom says that migraines reduce as people age - they are most common in the productive years and therefore migraine attacks should not be a
Migraine at 65 Medical wisdom says that migraines reduce as people age - they are most common in the productive years and therefore migraine attacks should not be a major problem in later life. Studies
More informationPost Traumatic and other Headache Syndromes. Danielle L. Erb, MD Brain Rehabilitation Medicine, LLC Brain Injury Rehab Center, PRA
Post Traumatic and other Headache Syndromes Danielle L. Erb, MD Brain Rehabilitation Medicine, LLC Brain Injury Rehab Center, PRA Over 45 million Americans have chronic, recurring headaches 62% of these
More informationWelcome to the program!
Calgary Headache Assessment & Management Program (CHAMP) EDUCATION SESSION Welcome to the program! Why is this Session Mandatory? Provide headache management information and orientation to the Champ program
More informationMedical Marijuana for the Treatment of Migraine Headaches: An Evidence Review
2012 Medical Marijuana for the Treatment of Migraine Headaches: An Evidence Review Doug Campos-Outcalt 1, MD, MPA Cecilia Rosales 2, MD, MS 1 UA College of Medicine-Phoenix and UA Zuckerman College of
More informationi n p r i m a r y c a r e *
Headache i n p r i m a r y c a r e * Key Advisers: Dr Neil Whittaker GP, Nelson Dr Alistair Dunn GP, Whangarei Expert Reviewer: Dr Alan Wright Neurologist, Dunedin Every headache presentation is unique
More informationReview of Pharmacological Pain Management
Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization
More informationWhen the Pain Won t Stop: Managing Chronic Daily Headache
When the Pain Won t Stop: Managing Chronic Daily Headache Arnolda Eloff, MB, ChB, Mmed Presented at the University of Calgary s Wednesday Evening Course Program, Calgary, Alberta. Copyright Chronic daily
More informationPreconception Clinical Care for Women Medical Conditions
Preconception Clinical Care for Women All women of reproductive age are candidates for preconception care; however, preconception care must be tailored to meet the needs of the individual. Given that preconception
More informationKids Get Headaches Too
health information Kids Get Headaches Too Alberta Health Services It is hard to see your child in pain. It can be frustrating or scary for a child to have headaches. In this booklet you will learn about:
More informationMigraines: Treatment Options Report
Migraines: Treatment Options Report April 2006 Migraines: Treatment Options Report Prepared for: CALIFORNIA HEALTHCARE FOUNDATION Prepared by: UC Davis Center for Health Services Research in Primary Care
More informationWhat s new, and why, in Neurology 4?
What s new, and why, in Neurology 4? All topics in Neurology 4 have been extensively reviewed and updated by the expert writing group, to provide concise evidence-based advice for the busy practitioner.
More informationClassification of Chronic Headache
Chronic Headache Classification of Chronic Headache JMAJ 47(3): 112 117, 2004 Mitsunori MORIMATSU Professor, Department of Neurology and Clinical Neuroscience, Yamaguchi University School of Medicine Abstract:
More informationManaging migraine in older patients
Migraine 637 Managing migraine in older patients Migraine is a common complaint in all age groups, but the diagnosis and treatment in an elderly population require special consideration. Dr Judith Pearson,
More informationNational Hospital for Neurology and Neurosurgery. Migraine associated dizziness Department of Neuro-otology
National Hospital for Neurology and Neurosurgery Migraine associated dizziness Department of Neuro-otology If you would like this document in another language or format or if you require the services of
More informationCommon Headaches- Diagnosis and Treatment
Common Headaches- Diagnosis and Treatment Anjaneyulu Alapati,M.D Honorary Clinical Professor UAB School of Medicine Huntsville, AL Headache-incidence Headache- patterns Minutes - vascular Hours to days-
More informationFEDERAL BUREAU OF PRISONS CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF HEADACHE September 2003
FEDERAL BUREAU OF PRISONS CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF HEADACHE September 2003 PURPOSE The Federal Bureau of Prisons Clinical Practice Guidelines for the Management of Headache provide
More informationDiagnosing and treating episodic migraine
D A N I S H H E A D A C H E C E N T E R Danish Headache Center Disclosures Diagnosing and treating episodic migraine M.A. is a consultant or scientific adviser for Allergan, Alder, Amgen, ATI, Bayer and
More informationWomen and Migraine: The Hormonal Link
Women and Migraine: The Hormonal Link March 1, 2012 Norma Jo Waxman, M.D. Associate Professor of Family and Community Medicine Bixby Center for Global Reproductive Health University of California San Francisco
More informationHEADACHE UK An alliance working for people with headache. School Policy Guidelines for School Students with Migraine and Troublesome Headache
HEADACHE UK An alliance working for people with headache School Policy Guidelines for School Students with Migraine and Troublesome Headache Content Background 2 Aim The extent and impact of the problem
More informationPractice parameter: Evidence-based guidelines for migraine headache (an evidence-based review)
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology Stephen D. Silberstein,
More informationOne Day at a Time: When Headaches Become Chronic. Robert Shapiro, MD, PhD
One Day at a Time: When Headaches Become Chronic Robert Shapiro, MD, PhD Disclosures Scientific/Medical Advisory Boards (since 10/12) Transcept Pharmaceuticals Chronic Headaches: Overview What is a chronic
More informationHeadaches. Myriam Camilleri. Summary. Differential Diagnosis. Introduction. Achieving the diagnosis. Incidence. Keywords.
In Practice Headaches Myriam Camilleri Summary A 30 year old lady was seen by her family doctor during a busy clinic complaining of three episodes of left-sided headache over the previous four months.
More informationRecognition and management of common headaches encountered in Primary Care. By Alan Gindoff DHSc, PA-C
Recognition and management of common headaches encountered in Primary Care By Alan Gindoff DHSc, PA-C Disclosure Statement Dr. Gindoff has no relevant financial or non financial relationships to disclose.
More informationMigraine and Related Headache Syndromes
neurology Board Review Manual Statement of Editorial Purpose The Hospital Physician Neurology Board Review Manual is a peer-reviewed study guide for residents and practicing physicians preparing for board
More informationMIGRAINE: QUESTIONS AND ANSWERS FOR PATIENTS Headache Research and Treatment Program Department of Neurology, David Geffen School of Medicine at UCLA
MIGRAINE: QUESTIONS AND ANSWERS FOR PATIENTS Headache Research and Treatment Program Department of Neurology, David Geffen School of Medicine at UCLA What is a migraine? Migraine is not just a headache,
More informationGuideline Panel Members
i Guideline Panel Members Saudi Expert Panel Dr. Adel Alhazzani Dr. Nasser Alotaibi Dr. Suleiman Mohammed Kojan Dr. Manal Abdulaziz Murad Dr. Mona Obaid McMaster University Working Group Dr. John J Riva,
More informationChronic daily headache
Chronic daily headache Chronic daily headache (CDH) is defined as any headache syndrome affecting more than half of the month, i.e. a headache on more than 15 days per month. It is also known as daily
More informationEuropean principles of management of common headache disorders in primary care. Scope and Purpose
in conjunction with Lifting The Burden The Global Campaign against Headache A collaboration between the World Health Organization, non-governmental organisations, academic institutions and individuals
More informationPrevention of Migraine
CHAPTER 49 Prevention of Migraine M. K. Roy, P. Ghosh Introduction Headache is a universal experience with 1 year prevalence of about 90% and life time prevalence of about 99%. The differential diagnosis
More informationUpdated guidelines on headache management for use by the pharmacist
M I P C A MIGRAINE IN PRIMARY CARE ADVISORS Updated guidelines on headache management for use by the pharmacist Introduction N U M B E R 2 1, O C T O B E R 2 0 1 2 Headache is a major public health problem,
More informationClinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients
Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Developed by the Mid Atlantic Renal Coalition and the Kidney End of Life Coalition September 2009 This project was supported,
More informationThe Pediatric Headache Handbook
The Pediatric Headache Handbook For the Primary Care Physician Brought to you by the Division of Child Neurology Classification of headache patterns in children Acute onset of worst headache of my life
More informationMigraines. Brought to you by the Waynesburg University Student Health Services
Migraines Brought to you by the Waynesburg University Student Health Services For God is not unjust; He will not forget your work and the love you showed for His name when you served the saints and you
More informationRefractory Migraine: Definition, Diagnosis, Management
Refractory Migraine: Definition, Diagnosis, Management Morris Levin, MD Associate Professor of Neurology Associate Professor of Psychiatry Dartmouth Medical School Co director, Dartmouth Headache Center
More information2.6.4 Medication for withdrawal syndrome
.6.3 Self-medication Self-medication presents a risk during alcohol withdrawal, particularly when there is minimal supervision (low level and medium level 1 settings). Inform patients of the risk of selfmedication
More informationBotulinum toxin in the treatment of chronic migraine. Gregory P. Hanes, MD Neuroscience Summit 5/14/15
Botulinum toxin in the treatment of chronic migraine Gregory P. Hanes, MD Neuroscience Summit 5/14/15 Primary Headache Disorders: Frequency Classification After Secondary Causes Are Ruled Out Short-Duration
More informationManagement of chronic headache
Neurology Roy Beran Management of chronic headache Background Headache remains the most common cause of neurological consultation in clinical practice for which correct diagnosis and treatment are essential.
More informationChronic Headaches. David R. Greeley, MD, FAAN Northwest Neurological, PLLC October 23, 2015
s David R. Greeley, MD, FAAN Northwest Neurological, PLLC October 23, 2015 Why is Headache Important? 36,000,000 people have migraine - more than asthma and diabetes combined 13,000,000 have chronic daily
More informationBOTOX Injection (Onabotulinumtoxin A) for Migraine Headaches [Preauthorization Required]
BOTOX Injection (Onabotulinumtoxin A) for Migraine Headaches [Preauthorization Required] Medical Policy: MP-RX-01-11 Original Effective Date: March 24, 2011 Reviewed: Revised: This policy applies to products
More informationChristy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla
Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Company Nature of Affiliation Unlabeled Product Usage Allergan Speaker None 4 Primary Headache Categories 8 Secondary
More informationare often attributed to cervical spondylosis, refractive errors or high blood pressure: evidence for such associations is poor. Headaches also follow
Pharmaceutical care when dispensing OTC medications for the symptomatic treatment of headaches. Pharmaceutical care of patients with disorders of local circulation Headache is an almost universal experience
More informationKids get headaches too! Evaluation and treatment of the pediatric headache
3:45 4:25pm Approach to the Child with Headaches SPEAKER Jason T. Lerner, MD Presenter Disclosure Information The following relationships exist related to this presentation: Jason T. Lerner, MD: No financial
More informationSUMMARY OF RECOMMENDATIONS
SUMMARY OF RECOMMENDATIONS FOR THE LONG- TERM TREATMENT OF RLS/WED from AN IRLSSG TASK FORCE Members of the Task Force Diego Garcia- Borreguero, MD, Madrid, Spain* Richard Allen, PhD, Baltimore, MD, USA*
More informationHeadaches when to worry is a scan always needed? Regan Solomons
Headaches when to worry is a scan always needed? Regan Solomons Introduction o Headache is a common problem in childhood o Up to 25% of school children suffer from chronic recurrent headaches o Primary
More informationMigraine headaches are a
PRACTICAL THERAPEUTICS Management of the Acute Migraine Headache GLEN AUKERMAN, M.D., DOUG KNUTSON, M.D., and WILLIAM F. MISER, M.D., M.A. Ohio State University College of Medicine and Public Health, Columbus,
More information